Cargando…

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

INTRODUCTION: During HIV-1 infection the B-cell compartment undergoes profound changes towards terminal differentiation, which are only partially restored by antiretroviral therapy (cART). MATERIALS AND METHODS: To investigate the impact of infection as early as during primary HIV-1 infection (PHI)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pogliaghi, Manuela, Ripa, Marco, Pensieroso, Simone, Tolazzi, Monica, Chiappetta, Stefania, Nozza, Silvia, Lazzarin, Adriano, Tambussi, Giuseppe, Scarlatti, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608708/ https://www.ncbi.nlm.nih.gov/pubmed/26474181 http://dx.doi.org/10.1371/journal.pone.0140435

Ejemplares similares

Levels of Soluble Endothelial Protein C Receptor Are Associated with CD4(+) Changes in Maraviroc-Treated HIV-Infected Patients
por: Nozza, Silvia, et al.
Publicado: (2012)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir
por: Gianotti, Nicola, et al.
Publicado: (2016)

Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children
por: Dispinseri, Stefania, et al.
Publicado: (2021)

Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV
por: Spitsin, Sergei, et al.
Publicado: (2021)

A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers
por: Bonato, Matteo, et al.
Publicado: (2017)

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy
por: Gianotti, Nicola, et al.
Publicado: (2015)

Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load
por: Galizzi, Nadia, et al.
Publicado: (2018)

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV
por: Valcour, Victor G., et al.
Publicado: (2015)

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
por: Krastinova, Evguenia, et al.
Publicado: (2015)

Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021)

Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males
por: Rovelli, Cristina, et al.
Publicado: (2017)

Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008–2018 in Italy
por: Nozza, Silvia, et al.
Publicado: (2021)

Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults
por: Mathiesen, Inger Hee, et al.
Publicado: (2017)

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Predictors of low ovarian reserve in cART-treated women living with HIV
por: Merlini, Esther, et al.
Publicado: (2021)

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4(+) T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele
por: Furci, Lucinda, et al.
Publicado: (1997)

Disseminated toxoplasmosis in an HIV positive patient in cART era
por: Cambrea, Simona Claudia, et al.
Publicado: (2014)

Anti-Tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART.
por: Tripiciano, Antonella, et al.
Publicado: (2021)

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART
por: Jacobson, Caron A., et al.
Publicado: (2012)

Effect of once-daily FDC treatment era on initiation of cART
por: Mosen, David M, et al.
Publicado: (2010)

Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART
por: Anzinger, Joshua J., et al.
Publicado: (2014)

Disruption of Timing: NeuroHIV Progression in the Post-cART Era
por: McLaurin, Kristen A., et al.
Publicado: (2019)

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

Bloodstream infections in patients living with HIV in the modern cART era
por: Taramasso, L., et al.
Publicado: (2019)

Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015)

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
por: Salido, Jimena, et al.
Publicado: (2021)

Prediction of virological failure in HIV-infected individuals treated with cART in Suriname
por: Bleijenberg, MP, et al.
Publicado: (2010)

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

Beneficial use of immunoglobulins in the treatment of Sydenham chorea
por: van Immerzeel, Tabitha D., et al.
Publicado: (2010)

Immunoglobulin Profile and Lymphocyte Subsets in Preterm Neonates
por: Sharma, Rahul, et al.
Publicado: (2022)

Discontinuation of cART postpartum in a high prevalence district of South Africa in 2014
por: Claessens, Lore, et al.
Publicado: (2014)

HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients
por: Valcour, Victor G., et al.
Publicado: (2013)

Is anemia still a problem in cART era: a single center study?
por: Genet, P, et al.
Publicado: (2014)

Impact of early cART on HIV blood and semen compartments at the time of primary infection
por: Chéret, Antoine, et al.
Publicado: (2017)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021)

MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review
por: Chaganti, Joga, et al.
Publicado: (2021)

Improved induced innate immune response after cART initiation in people with HIV
por: Hove-Skovsgaard, Malene, et al.
Publicado: (2022)

CART treatment improves memory and synaptic structure in APP/PS1 mice
por: Jin, Jia-li, et al.
Publicado: (2015)

Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART
por: Gianserra, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8cvkna9269nb38qg7bch4s2vnr